Moderna | MRNA - Loan Capital


Moderna reported $610M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Amgen USD 50B 2.43B Dec/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 158.75M 102.62M Jun/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 610M 584M Dec/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 37.75M 180K Sep/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tilray USD 279.22M 18.87M Mar/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025